Research and development of innovative pharmaceuticals in various therapeutic areas, including oncology, cardiovascular diseases, respiratory diseases, and immunology.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: April 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
GSK
A
Research and development of pharmaceuticals and vaccines focusing on respiratory, immunology, oncology, HIV, and infectious diseases.
AstraZeneca
B
Research, development, production, and marketing of prescription drugs in four therapeutic areas: cardiovascular, renal & metabolism, oncology, respiratory & immunology, and rare diseases.
Takeda
B
Development and commercialization of innovative medicines in various therapeutic areas, including gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Initiatives identified among leaders
Réduction des émissions de carbone
“GSK vise à réduire les émissions de carbone et a m...” - GSKFormation de professionnels de santé
“AstraZeneca forme des professionnels de santé pour...” - AstraZenecaDéveloppement de programmes de responsabilité sociale
“Takeda développe des programmes de responsabilité ...” - Takeda59% of similar organizations communicate on CSR issues
+1638 initiatives collected from 49 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports